Stock Screener App

Frei -

Installieren

4.3965

4.63% -0.2135

Taysha Gene Therapies Inc (TSHA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	1.986	2.302	2.022	1.788
Operating Expenses	18.39% 34.02	28.74	23.72	21.95	27.69
Benefits Costs and Expenses	13.39% 32.73	28.87	23.83	20.81	-
Costs And Expenses	13.39% 32.73	28.87	23.83	20.81	27.69
Operating Income/Loss	27.18% -34.02	-26.75	-21.42	-19.93	-25.90
Nonoperating Income/Loss	1,101% 1.291	-0.129	-0.108	1.147	0.374
Income/Loss From Continuing Operations Before Tax	21.77% -32.73	-26.88	-21.53	-18.79	1.788
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	21.77% -32.73	-26.88	-21.53	-18.79	-25.52
Net Income/Loss	21.77% -32.73	-26.88	-21.53	-18.79	-25.52
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	18.56% 353.31	297.99	269.31	6.0824	267.82
Diluted Average Shares	18.56% 353.31	297.99	269.31	6.0824	267.82
Basic Earnings Per Share	0.00% -0.09	-0.09	-0.08	-0.07	-0.10
Diluted Earnings Per Share	0.00% -0.09	-0.09	-0.08	-0.07	-0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters